Ren Nanamiya

554 total citations
29 papers, 347 citations indexed

About

Ren Nanamiya is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Ren Nanamiya has authored 29 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 13 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Ren Nanamiya's work include Monoclonal and Polyclonal Antibodies Research (10 papers), T-cell and B-cell Immunology (9 papers) and Chemokine receptors and signaling (9 papers). Ren Nanamiya is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), T-cell and B-cell Immunology (9 papers) and Chemokine receptors and signaling (9 papers). Ren Nanamiya collaborates with scholars based in Japan. Ren Nanamiya's co-authors include Mika K. Kaneko, Yukinari Kato, Teizo Asano, Junko Takei, Masato Sano, Hideki Hosono, Takuro Nakamura, Miyuki Yanaka, Tomohiro Tanaka and Tomohiro Tanaka and has published in prestigious journals such as International Journal of Molecular Sciences, British Journal of Cancer and Oncotarget.

In The Last Decade

Ren Nanamiya

29 papers receiving 347 citations

Peers

Ren Nanamiya

ONCOL

IMMUN

RNMI

SURGE

Hideki Hosono Japan

Svetlana Fayngerts United States

Francesca Avogadri-Connors United States

Saswata Basu United States

Dalal El‐Khoury United States

Chiyoko Nishime Japan

Faten El Hage France

Nicla Porciello Italy

Liane Höfferer Switzerland

Esmeralda Beck-Garcìa Germany

Hideki Hosono Japan

Ren Nanamiya

280 ×1.1

ONCOL

194 ×1.0

IMMUN

122 ×1.3

RNMI

121 ×1.3

38 ×1.2

SURGE

Citations per year, relative to Ren Nanamiya Ren Nanamiya (= 1×) peers Hideki Hosono

Countries citing papers authored by Ren Nanamiya

Since Specialization

Citations

This map shows the geographic impact of Ren Nanamiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ren Nanamiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ren Nanamiya more than expected).

Fields of papers citing papers by Ren Nanamiya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ren Nanamiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ren Nanamiya. The network helps show where Ren Nanamiya may publish in the future.

Co-authorship network of co-authors of Ren Nanamiya

This figure shows the co-authorship network connecting the top 25 collaborators of Ren Nanamiya. A scholar is included among the top collaborators of Ren Nanamiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ren Nanamiya. Ren Nanamiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Asano, Teizo, Tomohiro Tanaka, Yuki Okada, et al.. (2023). Epitope Mapping of Anti-Mouse CCR3 Monoclonal Antibodies (C ₃ Mab-6 and C ₃ Mab-7). Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 42(2). 68–72. 1 indexed citations

Saito, Masaki, Tomohiro Tanaka, Teizo Asano, et al.. (2022). C ₈ Mab-2: An Anti-Mouse C–C Motif Chemokine Receptor 8 Monoclonal Antibody for Immunocytochemistry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(2). 115–119. 8 indexed citations

Nanamiya, Ren, Hiroyuki Suzuki, Junko Takei, et al.. (2022). Development of Monoclonal Antibody 281-mG _2a -f Against Golden Hamster Podoplanin. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(6). 311–319. 9 indexed citations

Asano, Teizo, Hiroyuki Suzuki, Tomohiro Tanaka, et al.. (2022). C ₃ Mab-3: A Monoclonal Antibody for Mouse CC Chemokine Receptor 3 for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(2). 74–79. 16 indexed citations

Asano, Teizo, Tomohiro Tanaka, Hiroyuki Suzuki, et al.. (2022). Development of a Novel Anti-Mouse CCR6 Monoclonal Antibody (C ₆ Mab-13) by N-Terminal Peptide Immunization. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(6). 343–349. 2 indexed citations

Tanaka, Tomohiro, Hiroyuki Suzuki, Teizo Asano, et al.. (2022). Development of a Sensitive Anti-Human CCR9 Monoclonal Antibody (C ₉ Mab-11) by N-Terminal Peptide Immunization. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(6). 303–310. 3 indexed citations

Nanamiya, Ren, Junko Takei, Tomokazu Ohishi, et al.. (2022). Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody (134-mG _2a -f) Exerts Antitumor Activities in Mouse Xenograft Models of Canine Osteosarcoma. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(1). 1–7. 14 indexed citations

Tanaka, Tomohiro, Hiroyuki Suzuki, Teizo Asano, et al.. (2022). Epitope Mapping of an Anti-Mouse CCR2 Monoclonal Antibody (C ₂ Mab-6) Using Enzyme-Linked Immunosorbent Assay. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(6). 339–342. 1 indexed citations

Asano, Teizo, Tomokazu Ohishi, Junko Takei, et al.. (2021). An Anti-HER2 Monoclonal Antibody H ₂ Mab-41 Exerts Antitumor Activities in Mouse Xenograft Model Using Dog HER2-Overexpressed Cells. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(4). 184–190. 12 indexed citations

10.

Nanamiya, Ren, Junko Takei, Teizo Asano, et al.. (2021). Development of Anti-Human CC Chemokine Receptor 9 Monoclonal Antibodies for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(3). 101–106. 37 indexed citations

11.

Asano, Teizo, Ren Nanamiya, Junko Takei, et al.. (2021). Development of Anti-Mouse CC Chemokine Receptor 3 Monoclonal Antibodies for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(3). 107–112. 37 indexed citations

12.

Tanaka, Tomohiro, Teizo Asano, Masato Sano, et al.. (2021). Epitope Mapping of the Anti-California Sea Lion Podoplanin Monoclonal Antibody PMab-269 Using Alanine-Scanning Mutagenesis and ELISA. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(4). 196–200. 6 indexed citations

13.

Asano, Teizo, Ren Nanamiya, Tomohiro Tanaka, Mika K. Kaneko, & Yukinari Kato. (2021). Development of Antihuman Killer Cell Lectin-Like Receptor Subfamily G Member 1 Monoclonal Antibodies for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(2). 76–80. 8 indexed citations

14.

Nanamiya, Ren, Tomokazu Ohishi, Junko Takei, et al.. (2021). Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 134-mG _2a -f Exerts Antitumor Activities in Mouse Xenograft Models of Dog Epidermal Growth Factor Receptor-Overexpressed Cells. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(4). 177–183. 21 indexed citations

15.

Tanaka, Tomohiro, Ren Nanamiya, Junko Takei, et al.. (2021). Development of Anti-Mouse CC Chemokine Receptor 8 Monoclonal Antibodies for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(2). 65–70. 32 indexed citations

16.

Nanamiya, Ren, Junko Takei, Teizo Asano, et al.. (2021). Ferret Podoplanin Is Detected by PMab-241 in Immunohistochemistry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(3). 134–140. 1 indexed citations

17.

Tanaka, Tomohiro, Teizo Asano, Masato Sano, et al.. (2021). Development of Monoclonal Antibody PMab-269 Against California Sea Lion Podoplanin. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(3). 124–133. 25 indexed citations

18.

Nanamiya, Ren, Masato Sano, Teizo Asano, et al.. (2021). Epitope Mapping of an Anti-Human Epidermal Growth Factor Receptor Monoclonal Antibody (EMab-51) Using the RIEDL Insertion for Epitope Mapping Method. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(4). 149–155. 15 indexed citations

19.

Takei, Junko, Teizo Asano, Tomohiro Tanaka, et al.. (2021). Development of a Novel Anti-HER2 Monoclonal Antibody H ₂ Mab-181 for Gastric Cancer. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(4). 168–176. 7 indexed citations

20.

Takei, Junko, Teizo Asano, Ren Nanamiya, et al.. (2021). Development of Anti-human T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT) Monoclonal Antibodies for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(2). 71–75. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact